These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16952136)

  • 61. Inhibiting dihydrodipicolinate synthase across species: towards specificity for pathogens?
    Mitsakos V; Dobson RC; Pearce FG; Devenish SR; Evans GL; Burgess BR; Perugini MA; Gerrard JA; Hutton CA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):842-4. PubMed ID: 18054225
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis and biochemical evaluation of selective inhibitors of class II fructose bisphosphate aldolases: towards new synthetic antibiotics.
    Fonvielle M; Coinçon M; Daher R; Desbenoit N; Kosieradzka K; Barilone N; Gicquel B; Sygusch J; Jackson M; Therisod M
    Chemistry; 2008; 14(28):8521-9. PubMed ID: 18688832
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis of 3-alkyl enol mimics inhibitors of type II dehydroquinase: factors influencing their inhibition potency.
    Blanco B; Sedes A; Peón A; Lamb H; Hawkins AR; Castedo L; González-Bello C
    Org Biomol Chem; 2012 May; 10(18):3662-76. PubMed ID: 22447158
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors.
    Nilsson MT; Krajewski WW; Yellagunda S; Prabhumurthy S; Chamarahally GN; Siddamadappa C; Srinivasa BR; Yahiaoui S; Larhed M; Karlén A; Jones TA; Mowbray SL
    J Mol Biol; 2009 Oct; 393(2):504-13. PubMed ID: 19695264
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Irreversible inhibition of type I dehydroquinase by substrates for type II dehydroquinase.
    Bello CG; Harris JM; Manthey MK; Coggins JR; Abell C
    Bioorg Med Chem Lett; 2000 Mar; 10(5):407-9. PubMed ID: 10743936
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of 7,8-diaminopelargonic acid aminotransferase by amiclenomycin and analogues.
    Mann S; Marquet A; Ploux O
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):802-5. PubMed ID: 16042602
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents.
    Khoshneviszadeh M; Edraki N; Javidnia K; Alborzi A; Pourabbas B; Mardaneh J; Miri R
    Bioorg Med Chem; 2009 Feb; 17(4):1579-86. PubMed ID: 19162489
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art.
    Buroni S; Pasca MR; de Jesus Lopes Ribeiro AL; Degiacomi G; Molteni E; Riccardi G
    Appl Microbiol Biotechnol; 2012 May; 94(4):907-16. PubMed ID: 22526781
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
    Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
    Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Structural investigation of inhibitor designs targeting 3-dehydroquinate dehydratase from the shikimate pathway of Mycobacterium tuberculosis.
    Dias MV; Snee WC; Bromfield KM; Payne RJ; Palaninathan SK; Ciulli A; Howard NI; Abell C; Sacchettini JC; Blundell TL
    Biochem J; 2011 Jun; 436(3):729-39. PubMed ID: 21410435
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular modeling of a series of dehydroquinate dehydratase type II inhibitors of Mycobacterium tuberculosis and design of new binders.
    Miranda PHS; Lourenço EMG; Morais AMS; de Oliveira PIC; Silverio PSSN; Jordão AK; Barbosa EG
    Mol Divers; 2021 Feb; 25(1):1-12. PubMed ID: 31820222
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Implications of binding mode and active site flexibility for inhibitor potency against the salicylate synthase from Mycobacterium tuberculosis.
    Chi G; Manos-Turvey A; O'Connor PD; Johnston JM; Evans GL; Baker EN; Payne RJ; Lott JS; Bulloch EM
    Biochemistry; 2012 Jun; 51(24):4868-79. PubMed ID: 22607697
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Slow conformational dynamics of an endonuclease persist in its complex with its natural protein inhibitor.
    Whittaker SB; Czisch M; Wechselberger R; Kaptein R; Hemmings AM; James R; Kleanthous C; Moore GR
    Protein Sci; 2000 Apr; 9(4):713-20. PubMed ID: 10794413
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Structures of native, substrate-bound and inhibited forms of Mycobacterium tuberculosis imidazoleglycerol-phosphate dehydratase.
    Ahangar MS; Vyas R; Nasir N; Biswal BK
    Acta Crystallogr D Biol Crystallogr; 2013 Dec; 69(Pt 12):2461-7. PubMed ID: 24311587
    [TBL] [Abstract][Full Text] [Related]  

  • 76. NMR and molecular dynamics study of the binding mode of naphthalene-N-sulfonyl-D-glutamic acid derivatives: novel MurD ligase inhibitors.
    Simcic M; Hodoscek M; Humljan J; Kristan K; Urleb U; Kocjan D; Grdadolnik SG
    J Med Chem; 2009 May; 52(9):2899-908. PubMed ID: 19358612
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phosphate closes the solution structure of the 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) from Mycobacterium tuberculosis.
    Borges JC; Pereira JH; Vasconcelos IB; dos Santos GC; Olivieri JR; Ramos CH; Palma MS; Basso LA; Santos DS; de Azevedo WF
    Arch Biochem Biophys; 2006 Aug; 452(2):156-64. PubMed ID: 16876105
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antituberculosis drugs: ten years of research.
    Janin YL
    Bioorg Med Chem; 2007 Apr; 15(7):2479-513. PubMed ID: 17291770
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Purification and characterization of anthranilate synthase component I (TrpE) from Mycobacterium tuberculosis H37Rv.
    Lin X; Xu S; Yang Y; Wu J; Wang H; Shen H; Wang H
    Protein Expr Purif; 2009 Mar; 64(1):8-15. PubMed ID: 18952181
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 2-Chloro-6-(2-furyl)-9-(4-methoxybenzyl)-9H-purine.
    Braendvang M; Gundersen LL
    Acta Crystallogr C; 2007 May; 63(Pt 5):o274-6. PubMed ID: 17478910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.